149 related articles for article (PubMed ID: 36571)
1. Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets.
Lasch P; Jakobs KH
Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):119-25. PubMed ID: 36571
[No Abstract] [Full Text] [Related]
2. Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets.
Jakobs KH
Nature; 1978 Aug; 274(5673):819-20. PubMed ID: 28484
[No Abstract] [Full Text] [Related]
3. Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.
Jakobs KH; Saur W; Schultz G
Naunyn Schmiedebergs Arch Pharmacol; 1978 May; 302(3):285-91. PubMed ID: 26887
[No Abstract] [Full Text] [Related]
4. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Clare KA; Scrutton MC; Thompson NT
Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
[TBL] [Abstract][Full Text] [Related]
5. Identification of alpha-adrenergic receptors in human platelets by [3H]dihydroergocryptine binding.
Newman KD; Williams LT; Bishopric NH; Lefkowitz RJ
J Clin Invest; 1978 Feb; 61(2):395-402. PubMed ID: 23392
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of human platelet adrenoceptors.
Barnett DB; Swart SS; Nahorski SR; Cook N
Adv Exp Med Biol; 1985; 192():97-108. PubMed ID: 2871708
[No Abstract] [Full Text] [Related]
7. Effects of prostaglandin E2 on human platelet adenyl cyclase and aggregation.
Bruno JJ; Taylor LA; Droller MJ
Nature; 1974 Oct; 251(5477):721-3. PubMed ID: 4427671
[No Abstract] [Full Text] [Related]
8. Transregulation of the alpha2-adrenergic signal transduction pathway by chronic beta-blockade: a novel mechanism for decreased platelet aggregation in patients.
Schwencke C; Schmeisser A; Weinbrenner C; Braun-Dullaeus RC; Marquetant R; Strasser RH
J Cardiovasc Pharmacol; 2005 Mar; 45(3):253-9. PubMed ID: 15725951
[TBL] [Abstract][Full Text] [Related]
9. Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients.
Karege F; Bovier P; Hilleret H; Gaillard JM
Lancet; 1993 Apr; 341(8851):1029. PubMed ID: 8096917
[No Abstract] [Full Text] [Related]
10. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
[TBL] [Abstract][Full Text] [Related]
11. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
12. Human platelet alpha-adrenergic receptors and responses during pregnancy: no change except that with differing hematocrit.
Roberts JM; Lewis V; Mize N; Tsuchiya A; Starr J
Am J Obstet Gynecol; 1986 Jan; 154(1):206-10. PubMed ID: 2868662
[TBL] [Abstract][Full Text] [Related]
13. 5'-Methylthioadenosine and 2',5'-dideoxyadenosine blockade of the inhibitory effects of adenosine on ADP-induced platelet aggregation by different mechanisms.
Agarwal KC; Parks RE
Biochem Pharmacol; 1980 Sep; 29(18):2529-32. PubMed ID: 6968562
[No Abstract] [Full Text] [Related]
14. Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity.
Ferry N; Henry D; Battais E; Mary A; Bonne C; Hanoune J
Biochem Pharmacol; 1986 May; 35(9):1511-6. PubMed ID: 2871841
[TBL] [Abstract][Full Text] [Related]
15. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
16. Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.
Grant JA; Scrutton MC
Br J Pharmacol; 1980; 71(1):121-34. PubMed ID: 6110451
[TBL] [Abstract][Full Text] [Related]
17. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of vitamin E on platelet function.
Steiner M; Mower R
Ann N Y Acad Sci; 1982; 393():289-99. PubMed ID: 6293365
[No Abstract] [Full Text] [Related]
19. Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase.
Colli S; Maderna P; Tremoli E; Baraldi A; Rovati GE; Gianfranceschi G; Nicosia S
Biochem Pharmacol; 1985 Jul; 34(14):2451-7. PubMed ID: 3893439
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
Kahn NN; Sinha AK
Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
